Rare variant contribution to human disease in 281,104 UK Biobank exomes
Quanli Wang, Anna Reznichenko(AstraZeneca (Sweden)), Maria G. Belvisi(Lung Institute), Bolan Linghu(AstraZeneca (United Kingdom)), Benjamin Challis(Wellcome/MRC Institute of Metabolic Science), Kieren Lythgow(AstraZeneca (United Kingdom)), Zhongwu Lai(AstraZeneca (United States)), Alex Mackay(University of Wollongong), Susan J. Monkley(AstraZeneca (Sweden)), Dirk S. Paul(AstraZeneca (United Kingdom)), Fengyuan Hu(Babraham Institute), Michael Hühn(AstraZeneca (Sweden)), Mohammad Bohlooly‐Y(AstraZeneca (Sweden)), Regina Fritsche Danielson(AstraZeneca (United States)), Pernille Hansen(AstraZeneca (United Kingdom)), Abhishek Nag(King's College London), Oliver S. Burren(AstraZeneca (United Kingdom)), Erik Michaëlsson(AstraZeneca (Sweden)), Andrew R. Harper(AstraZeneca (United Kingdom)), Athena Matakidou(AstraZeneca (Sweden)), Peter Maccallum(AstraZeneca (United Kingdom)), Xiao Jiang(AstraZeneca (Sweden)), Ryan S. Dhindsa(Baylor College of Medicine), Sophia Cameron‐Christie(AstraZeneca (United Kingdom)), Henric Olsson(AstraZeneca (Sweden)), Daniel Muthas(AstraZeneca (Sweden)), Benjamin Georgi(AstraZeneca (United Kingdom)), Sven Moosmang(Boehringer Ingelheim (Germany)), Zara Ghazoui(AstraZeneca (Sweden)), Lisa Buvall(AstraZeneca (United Kingdom)), Dimitrios Vitsios(AstraZeneca (United Kingdom)), Glenda Lassi(AstraZeneca (United Kingdom)), Sean M. O’Dell(Geisinger Medical Center), Brian Dougherty(AstraZeneca (United States)), Joel Okae(AstraZeneca (United Kingdom)), Ronen Artzi(AstraZeneca (United States)), E. Suzanne Cohen(AstraZeneca (Switzerland)), Bastian R. Angermann(AstraZeneca (United Kingdom)), Andrew Davis(AstraZeneca (Sweden)), Sri V. V. Deevi(University of Cambridge), Ioanna Tachmazidou(AstraZeneca (United Kingdom)), Chanchal Kumar(Vignana Jyothi Institute of Management), Amanda O’Neill(University of Cambridge), Carl Barrett(AstraZeneca (United Kingdom)), Magda Jeznach(AstraZeneca (United Kingdom)), Samuel H. Lewis(AstraZeneca (United States)), Yoichiro Ohne(AstraZeneca (Sweden)), Carla Martins(AstraZeneca (United Kingdom)), Keren Carss(AstraZeneca (United Kingdom))
Cited by 597
Related Papers
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T <sub>reg</sub> Cell Homeostasis
|Science|2013|5.3k
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
|Nature Medicine|2015|1.5k
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
|Science Signaling|2010|1.5k